SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar Automotive Holding UK PLC

Polestar is trending as investors digest the company's recent equity capital raise and strategic shift toward Europe, while navigating market volatility surrounding its long-term growth targets. Community discourse remains deeply divided between those viewing the new model pipeline and Geely's continued financial backing as signs of a turnaround, and those expressing frustration over ongoing cash burn and the impact of broader geopolitical tensions.

GraniteShares ETF Trust - GraniteShares 2x Long MU Daily ETF

GraniteShares 2x Long MU Daily ETF

Investors are actively trading GraniteShares 2x Long MU Daily ETF (MULL) to amplify exposure to Micron's AI-driven growth, with community members heavily debating the risks of leveraged decay versus the potential for outsized gains. Discussions often center on long-term confidence in Micron's memory market position alongside strategies for scaling positions during volatility.

Nintendo Co., Ltd. engages in the development, manufacture, and sale of home entertainment products. Its entertainment products include portable and console game machines and software, trump cards and Karuta (Japanese-style playing cards), multinational consumer electronics, home console hardware such as Nintendo Wii, Nintendo DS, Nintendo 3DS, as well as software for handheld and home console gaming machines. The company was founded by Fusajiro Yamauchi on September 23, 1889 and is headquartered in Kyoto, Japan.

Nintendo Co. Ltd - ADR

Nintendo is facing intense market scrutiny as investors weigh record-breaking Switch 2 hardware sales against concerns regarding margin compression from rising memory costs and chip supply chain constraints. While the community remains deeply divided between long-term confidence in the company's robust IP monetization strategy and frustration over the stock's recent volatility, many are closely monitoring upcoming software releases and expansion into non-gaming media to gauge the next leg of growth.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereum is facing intense volatility as the market reacts to shifting regulatory signals and the fallout from broad crypto-sector liquidations. While some institutional players continue to accumulate assets based on long-term infrastructure potential, community sentiment remains sharply divided between those calling for a structural reset and others highlighting the potential for a rebound driven by institutional integration.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) is trending due to the complex geopolitical fallout from the ongoing conflict with Iran, which has severely disrupted global oil supply chains through the Strait of Hormuz. The community is actively debating the durability of supply shortages, the impact of potential diplomatic frameworks or sanctions relief, and whether energy stocks represent an oversold value opportunity amid persistent concerns about global inventory depletion and structural energy scarcity.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is seeing heightened investor attention as the community anticipates potential regulatory developments and ETF updates, though sentiment remains polarized by ongoing debates surrounding the impact of token dilution on performance. Meanwhile, the native Cronos meme coin $MERY.X is gaining traction among traders who highlight its strong correlation with CRO and its community-led, 'rug-proof' narrative as primary drivers of interest.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia is currently trending due to strong commercial momentum from its Yutrepia launch, with investors closely watching for a potential patent ruling that could serve as a major catalyst. The community is actively debating the stock's valuation, profitability, and market share potential against established competitors in the rare disease biotech space.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The Financial Select Sector SPDR Fund ($XLF) is currently seeing heavy bearish sentiment as investors weigh persistent inflation concerns, weakening loan growth, and systemic risks within private credit. The community is actively debating whether recent price action signifies a structural breakdown or a temporary rotation, with many traders closely monitoring large bank stability and interest rate sensitivity ahead of upcoming sector-wide catalysts.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors aggressively hedge against potential market volatility and a possible AI bubble, fueled by fears of overvaluation, geopolitical tensions, and looming economic data. Community discussion is heavily focused on the disconnect between high-flying tech valuations and broader macroeconomic concerns, with many traders using the symbol to capitalize on perceived market manipulation and downside momentum.

WorldFinancial

World Liberty Financial is trending as investors debate a controversial governance vote to lock up over 60 billion tokens, sparking intense community backlash and accusations of a long-term rug pull. While some traders are betting on a supply-shock-driven reversal, the token continues to face record lows, drawing heavy criticism from those who label it a scam orchestrated by the Trump family.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Strength Seen in Kymera Therapeutics (KYMR): Can Its 16.6% Jump Turn into More Strength?

Kymera Therapeutics (KYMR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Biotech Surges as Big Money Backs High-Stakes Kidney Disease Push

The immune system has become one of biotech's most important battlegrounds as drug developers race to target inflammatory pathways responsible for some of medicine's most difficult-to-treat diseases. Among the most closely watched areas is the complement system, a network of proteins that can trigger severe tissue damage when overactivated. With growing interest in kidney disorders and autoimmune diseases, investors are increasingly rewarding companies developing targeted therapies capable of interrupting these pathways with greater precision and fewer side effects.Shares of InflaRx N.V. ...

InflaRx N.V. (NASDAQ:IFRX) Short Interest Update

InflaRx N.V. (NASDAQ:IFRX - Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totaling 1,809,027 shares, a decline of 26.2% from the March 31st total of 2,452,174 shares. Approximately 3.0% of the company's stock are short...

InflaRx (IFRX) Expected to Announce Quarterly Earnings on Wednesday

InflaRx (NASDAQ:IFRX) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-inflarx-stock...

InflaRx (NASDAQ:IFRX) Coverage Initiated at Oppenheimer

Oppenheimer initiated coverage on InflaRx in a report on Friday. They set an "outperform" rating and a $5.00 price target on the stock...

InflaRx's (IFRX) "Buy" Rating Reaffirmed at Guggenheim

Guggenheim reiterated a "buy" rating and set a $14.00 price target on shares of InflaRx in a report on Tuesday...

InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

InflaRx N.V. (NASDAQ:IFRX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy ratin...

InflaRx (NASDAQ:IFRX) Stock Price Up 32.5% - Should You Buy?

InflaRx (NASDAQ:IFRX) Stock Price Up 32.5% - Still a Buy...

InflaRx N.V. (NASDAQ:IFRX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of InflaRx N.V. (NASDAQ:IFRX - Get Free Report) have received a consensus rating of "Moderate Buy" from the seven brokerages that are covering the stock, Marketbeat Ratings reports. One...

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

InflaRx N.V.

IFRX Stock Soars Pre-Market After Experimental Drug Shows Promise In Treating Chronic Skin Diseases

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

IFRXInflaRx N.V.

Fundamentals

Latest IFRX News